Shopping Cart
Remove All
Your shopping cart is currently empty
Epratuzumab (AMG 41) is a humanized monoclonal antibody targeting CD22, also a tumor imaging agent that induces CD22 phosphorylation. It is used in autoimmune disease research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $213 | In Stock | In Stock | |
| 5 mg | $558 | - | In Stock | |
| 10 mg | $893 | - | In Stock | |
| 25 mg | $1,320 | - | In Stock | |
| 50 mg | $1,780 | - | In Stock |
| Description | Epratuzumab (AMG 41) is a humanized monoclonal antibody targeting CD22, also a tumor imaging agent that induces CD22 phosphorylation. It is used in autoimmune disease research. |
| In vitro | Epratuzumab binds to the CD22 extracellular domain with an affinity of K (D) = 0.7 nM. Epratuzumab binds to B cell lines or primary B cells from patients with NHL, resulting in rapid internalization of the CD22/ antibody complex. [1] |
| Synonyms | Anti-Human CD22 Recombinant Antibody, Antibody hLL 2, AMG41, AMG 41 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 205923-57-5 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.